SUN PHARMACEUTICAL INDUSTRIES (SUNPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 10,930.67 11,940.84 12,192.41 12,380.70 11,982.90 12,652.75 13,291.39 13,675.46 12,958.84 13,851.40 14,478.31 15,520.54
YOY Revenue Growth % 15.71% 10.96% 11.32% 10.14% 9.63% 5.96% 9.01% 10.46% 8.14% 9.47% 8.93% 13.49%
Other Income 373.28 204.44 293.61 250.20 605.94 532.55 354.00 465.62 612.87 464.46 469.92 578.84
Total Income 11,303.95 12,145.28 12,486.02 12,630.90 12,588.84 13,185.30 13,645.39 14,141.08 13,571.71 14,315.86 14,948.23 16,099.38
Total Expenses + 7,778.26 7,703.39 7,891.39 7,876.59 8,244.07 7,926.71 8,296.95 8,334.21 9,955.68 10,325.09 10,780.62 11,382.74
Cost of Materials Consumed 1,899.94 1,852.49 1,665.45 1,709.66 1,676.73 1,557.01 1,638.72 1,408.31 1,845.06 1,771.59 1,621.51 1,813.48
Employee Benefit Expense 2,179.55 2,402.04 2,364.36 2,363.32 2,299.34 2,454.62 2,477.70 2,552.28 2,488.52 2,801.66 2,764.79 2,892.00
Other Expenses 3,698.77 3,448.86 3,861.58 3,803.61 4,268.00 3,915.08 4,180.53 4,373.62 4,117.04 3,933.32 4,203.74 4,734.95
Operating Profit 3,152.41 4,237.45 4,301.02 4,504.11 3,738.83 4,726.04 4,994.44 5,341.25 3,003.16 3,526.31 3,697.69 4,137.80
OPM % 28.8% 35.5% 35.3% 36.4% 31.2% 37.4% 37.6% 39.1% 23.2% 25.5% 25.5% 26.7%
Profit Before Tax + 2,239.69 2,481.14 2,790.88 3,000.35 2,815.52 3,423.50 3,597.88 3,476.40 3,254.35 3,172.77 4,167.61 4,227.16
Tax Expense 256.79 475.49 405.78 439.81 156.78 562.99 560.55 563.42 1,100.42 879.90 1,042.66 845.99
Tax % 11.5% 19.2% 14.5% 14.7% 5.6% 16.4% 15.6% 16.2% 33.8% 27.7% 25% 20%
Profit After Tax 1,982.90 2,005.65 2,385.10 2,560.54 2,658.74 2,860.51 3,037.33 2,912.98 2,153.93 2,292.87 3,124.95 3,381.17
EPS (Basic) 8.30 8.40 9.90 10.50 11.10 11.80 12.70 12.10 9.00 9.50 13.00 14.00

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2020 Mar 2019 Mar 2018
Revenue from Operations 52,578.44 48,496.85 43,885.68 38,654.49 32,837.50 29,065.91 26,489.46
YOY Revenue Growth % 8.42% 10.51% 13.53% 17.71% 12.98% 9.73% -
Other Income 1,965.04 1,354.19 634.52 921.51 635.98 1,025.49 838.76
Total Income 54,543.48 49,851.04 44,520.20 39,576.00 33,473.48 30,091.40 27,328.22
Total Expenses + 40,113.50 31,715.44 29,354.30 24,954.35 22,132.52 20,672.05 17,919.25
Cost of Materials Consumed 6,449.10 6,904.33 7,777.57 7,049.12 5,515.23 5,782.70 4,462.60
Employee Benefit Expense 9,973.12 9,429.06 8,296.03 7,300.83 6,362.35 5,967.09 5,367.05
Other Expenses 16,586.27 15,382.05 13,280.70 10,604.40 10,254.94 8,922.26 8,089.60
Operating Profit 12,464.94 16,781.41 14,531.38 13,700.14 10,704.98 8,393.86 8,570.21
OPM % 23.7% 34.6% 33.1% 35.4% 32.6% 28.9% 32.4%
Profit Before Exceptional 14,429.98 11,582.21 9,579.88 9,048.14 5,270.23 5,024.58 4,429.48
Exceptional Items -677.85 -494.32 -171.45 -4,566.82 -260.64 -1,214.38 -950.50
Profit Before Tax + 13,752.13 11,087.89 9,408.43 4,481.32 5,009.59 3,810.20 3,478.98
Tax Expense 2,787.38 1,477.86 895.49 1,092.04 837.63 602.34 870.63
Tax % 20.3% 13.3% 9.5% 24.4% 16.7% 15.8% 25%
Profit After Tax 10,964.75 9,610.03 8,512.94 3,389.28 4,171.96 3,207.86 2,608.35
EPS (Basic) 45.60 39.90 35.30 13.60 15.69 11.11 9.00

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2020 Mar 2019 Mar 2018
ASSETS
Non-Current Assets + 39,476.11 41,987.90 40,860.25 0.00 0.00 0.00 0.00
Property, Plant & Equipment 10,035.94 10,192.32 10,390.38 0.00 0.00 0.00 0.00
Capital Work in Progress 1,234.34 1,107.73 963.35 0.00 0.00 0.00 0.00
Non-Current Investments 4,248.97 5,998.62 5,068.09 0.00 0.00 0.00 0.00
Goodwill 8,939.42 8,598.95 8,712.71 0.00 0.00 0.00 0.00
Other Intangible Assets 3,610.92 4,420.11 5,317.03 0.00 0.00 0.00 0.00
Current Assets + 52,594.06 43,433.11 39,861.94 0.00 0.00 0.00 0.00
Inventories 10,243.33 9,868.29 10,513.05 0.00 0.00 0.00 0.00
Trade Receivables 13,046.11 11,249.37 11,438.51 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 10,268.77 9,285.65 4,623.73 0.00 0.00 0.00 0.00
Current Investments 1,000.00 1,000.00 1,000.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 239.93 239.93 239.93 0.00 0.00 0.00 0.00
Other Equity 71,978.09 63,426.82 55,755.45 0.00 0.00 0.00 0.00
Non-Current Liabilities 1,420.42 1,372.51 1,521.12 0.00 0.00 0.00 0.00
Current Liabilities 18,194.21 16,983.77 19,906.38 0.00 0.00 0.00 0.00
Total Liabilities 19,614.63 18,356.91 21,428.12 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2020 Mar 2019 Mar 2018
Cash from Operating Activities 14,072.09 12,134.98 4,959.33 8,984.54 0.00 0.00 0.00
Cash from Investing Activities -5,306.16 -690.20 -7,943.68 -5,724.74 0.00 0.00 0.00
Cash from Financing Activities -7,905.82 -6,710.16 2,376.07 -5,193.46 0.00 0.00 0.00
Net Increase/Decrease in Cash 983.12 4,661.92 115.48 -1,764.78 0.00 0.00 0.00